Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
Abstract
INTRODUCTION
Human ether-à-go-go related gene (hERG) is responsible for channels that mediate the rapid delayed rectifier K(+) channel
current (I(Kr) ), which participates in repolarization of the ventricles and is a target for some antiarrhythmic drugs. Acidosis
occurs in the heart in some pathological situations and can modify the function and responses to drugs of ion channels. The
aim of this study was to determine the effects of extracellular and intracellular acidosis on the potency of hERG channel
current (I(hERG)) inhibition by the antiarrhythmic agents dofetilide, flecainide, and amiodarone at 37 °C.
METHODS AND RESULTS
Whole-cell patch-clamp recordings of I(hERG) were made at 37 °C from hERG-expressing Human Embryonic Kidney (HEK293) cells.
Half-maximal inhibitory concentration (IC(50)) values for I(hERG) tail inhibition at -40 mV following depolarizing commands
to +20 mV were significantly higher at external pH 6.3 than at pH 7.4 for both flecainide and dofetilide, but not for amiodarone.
Lowering pipette pH from 7.2 to 6.3 altered neither I(hERG) kinetics nor the extent of observed I(hERG) blockade by any of
these drugs.
CONCLUSION
Conditions leading to localized extracellular acidosis may facilitate heterogeneity of action of dofetilide and flecainide,
but not amiodarone via modification of hERG channel blockade. Such effects depend on the external pH change rather than intracellular
acidification.
Links
Authors
DU CY, El Harchi A, Zhang YH, Orchard CH, Hancox JC
Institution
School of Physiology and Pharmacology, Bristol Heart Institute, Medical Sciences Building, The University of Bristol, Bristol, UK.
Source
Journal of cardiovascular electrophysiology 22:10 2011 Oct pg 1163-70MeSH
AcidosisAmiodarone
Anti-Arrhythmia Agents
Dose-Response Relationship, Drug
Ether-A-Go-Go Potassium Channels
Flecainide
HEK293 Cells
Humans
Hydrogen-Ion Concentration
Membrane Potentials
Patch-Clamp Techniques
Phenethylamines
Potassium
Potassium Channel Blockers
Sulfonamides
Time Factors
Transfection
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
21489024
Log In

